Versant Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AAMU
AAP
SOADOR
YCM
LSERS
COPPSERS
QCM
Versant Capital Management's VCYT Position: Q2 2026 in Review
Versant Capital Management reduced its Veracyte (VCYT) stake by 11% in Q2 2026, selling an estimated $1.38K and leaving 261 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2063.
Versant Capital Management first reported a position in VCYT in Q2 2023 and has held it in 11 quarters since. The position peaked at $27.6K in Q1 2025. 32 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Versant Capital Management held 261 shares of Veracyte worth $15.3K as of Q2 2026.
- Versant Capital Management sold 33 Veracyte shares in Q2 2026, an estimated $1.38K.
- Veracyte made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2063 holding.
- Versant Capital Management first reported a position in Veracyte in Q2 2023 and has held it in 11 quarters since.
- Versant Capital Management's Veracyte position peaked at $27.6K in Q1 2025.
- 32 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.